Janković, Ljiljana

Link to this page

Authority KeyName Variants
f34d015d-5835-4cfa-a4e2-bb0f7f9083c8
  • Janković, Ljiljana (23)
Projects

Author's Bibliography

Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis

Bijelić, Borivoj; Matić, Ivana Z.; Besu, Irina; Janković, Ljiljana; Juranić, Zorica; Marusić, Senka; Andrejević, Slađana

(Elsevier Gmbh, Munich, 2019)

TY  - JOUR
AU  - Bijelić, Borivoj
AU  - Matić, Ivana Z.
AU  - Besu, Irina
AU  - Janković, Ljiljana
AU  - Juranić, Zorica
AU  - Marusić, Senka
AU  - Andrejević, Slađana
PY  - 2019
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/2456
AB  - The etiology of recurrent aphthous stomatitis (RAS) remains unknown. RAS can be presented as primary, idiopathic condition and as a secondary RAS, which is associated with a systemic disease. The aim of our study was to evaluate the presence and concentrations of antibodies specific for celiac disease (CeD) and antibodies related to inflammatory bowel diseases (IBD) in patients with RAS without gastrointestinal symptoms. Antibodies against tissue transglutaminase (anti-tTG), deaminated gliadin peptides (DGP), deaminated gliadinanalogous fragments (anti-GAF-3X) and Saccharomyces cerevisiae (ASCA) were determined by ELISA and anti-neutrophil cytoplasmic antibodies (ANCA) by indirect immunoflurescence (IIF) in 57 patients with RAS and 60 control subjects. The prevalence of CeD specific antibodies did not differ between RAS patients and controls. However, the concentrations of IgA anti-tTG, IgA anti-GAF-3X antibodies in patients with RAS were significantly higher compared to controls (p = 0.002 and p = 0.04 respectively). Histological changes consistent with CeD were confirmed by duodenal biopsy in one RAS patient with highly positive IgA anti-tTG, anti-GAF-3X and anti-DGP antibodies. Higher prevalence along with higher concentrations of IgG ASCA were found in RAS patients compared to controls (p  lt  0.01). Patients with positive IgG ASCA in the absence of clinical symptoms decided not to pursue any further testing. Dysfunction of oral mucosa and the exposure to various antigens might be a reason for the loss of tolerance resulting in increased production of autoantibodies. It seems likely that antibodies are markers of aberrant immune response, rather than key effectors involved in the pathogenesis of the disease.
PB  - Elsevier Gmbh, Munich
T2  - Immunobiology
T1  - Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis
VL  - 224
IS  - 1
SP  - 75
EP  - 79
DO  - 10.1016/j.imbio.2018.10.006
ER  - 
@article{
author = "Bijelić, Borivoj and Matić, Ivana Z. and Besu, Irina and Janković, Ljiljana and Juranić, Zorica and Marusić, Senka and Andrejević, Slađana",
year = "2019",
abstract = "The etiology of recurrent aphthous stomatitis (RAS) remains unknown. RAS can be presented as primary, idiopathic condition and as a secondary RAS, which is associated with a systemic disease. The aim of our study was to evaluate the presence and concentrations of antibodies specific for celiac disease (CeD) and antibodies related to inflammatory bowel diseases (IBD) in patients with RAS without gastrointestinal symptoms. Antibodies against tissue transglutaminase (anti-tTG), deaminated gliadin peptides (DGP), deaminated gliadinanalogous fragments (anti-GAF-3X) and Saccharomyces cerevisiae (ASCA) were determined by ELISA and anti-neutrophil cytoplasmic antibodies (ANCA) by indirect immunoflurescence (IIF) in 57 patients with RAS and 60 control subjects. The prevalence of CeD specific antibodies did not differ between RAS patients and controls. However, the concentrations of IgA anti-tTG, IgA anti-GAF-3X antibodies in patients with RAS were significantly higher compared to controls (p = 0.002 and p = 0.04 respectively). Histological changes consistent with CeD were confirmed by duodenal biopsy in one RAS patient with highly positive IgA anti-tTG, anti-GAF-3X and anti-DGP antibodies. Higher prevalence along with higher concentrations of IgG ASCA were found in RAS patients compared to controls (p  lt  0.01). Patients with positive IgG ASCA in the absence of clinical symptoms decided not to pursue any further testing. Dysfunction of oral mucosa and the exposure to various antigens might be a reason for the loss of tolerance resulting in increased production of autoantibodies. It seems likely that antibodies are markers of aberrant immune response, rather than key effectors involved in the pathogenesis of the disease.",
publisher = "Elsevier Gmbh, Munich",
journal = "Immunobiology",
title = "Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis",
volume = "224",
number = "1",
pages = "75-79",
doi = "10.1016/j.imbio.2018.10.006"
}
Bijelić, B., Matić, I. Z., Besu, I., Janković, L., Juranić, Z., Marusić, S.,& Andrejević, S.. (2019). Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis. in Immunobiology
Elsevier Gmbh, Munich., 224(1), 75-79.
https://doi.org/10.1016/j.imbio.2018.10.006
Bijelić B, Matić IZ, Besu I, Janković L, Juranić Z, Marusić S, Andrejević S. Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis. in Immunobiology. 2019;224(1):75-79.
doi:10.1016/j.imbio.2018.10.006 .
Bijelić, Borivoj, Matić, Ivana Z., Besu, Irina, Janković, Ljiljana, Juranić, Zorica, Marusić, Senka, Andrejević, Slađana, "Celiac disease-specific and inflammatory bowel disease-related antibodies in patients with recurrent aphthous stomatitis" in Immunobiology, 224, no. 1 (2019):75-79,
https://doi.org/10.1016/j.imbio.2018.10.006 . .
12
4
7

The efficacy of fluoxetine in BMS-A cross-over study

Zorić, Bojana; Janković, Ljiljana; Kuzmanović-Pfićer, Jovana; Zidverc-Trajković, Jasna; Mijajlović, Milija; Stanimirović, Dragan

(Wiley, Hoboken, 2018)

TY  - JOUR
AU  - Zorić, Bojana
AU  - Janković, Ljiljana
AU  - Kuzmanović-Pfićer, Jovana
AU  - Zidverc-Trajković, Jasna
AU  - Mijajlović, Milija
AU  - Stanimirović, Dragan
PY  - 2018
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/2288
AB  - Background: Burning mouth syndrome (BMS) is an intraoral burning or dysaesthetic sensation, recurring daily for more than two hours during the period longer than 3 months. The objective was to evaluate and analyse the efficacy of serotonin reuptake inhibitor fluoxetine on psychological factors, as well as on pain in participants with BMS. Methods: In a 6-month study, 100 participants with primary and secondary BMS were divided into two groups-fluoxetine and control (placebo) and examined by the dentist and the neurologist. Depression and anxiety were estimated by Hamilton Scale for Depression (HAM-D) and Anxiety (HAM-A) and Beck Depression Inventory (BDI) and the pain intensity by visual analogue scale (VAS). Results: Mean age of the participants was 60.33 in fluoxetine group and 67.4 in control group. Most of the participants were female-74% in the fluoxetine and 78% in the control group. Statistical difference between the fluoxetine and the control group was found in HAM-D results (P  lt  .05). Values of other scales and VAS decreased significantly after the therapy in both groups (P  lt  .05). Conclusions: Our trial results indicate that fluoxetine therapy not only improves the psychological status of participants with BMS but also fluoxetine decreases the intensity of pain in these patients.
PB  - Wiley, Hoboken
T2  - Gerodontology
T1  - The efficacy of fluoxetine in BMS-A cross-over study
VL  - 35
IS  - 2
SP  - 123
EP  - 128
DO  - 10.1111/ger.12332
ER  - 
@article{
author = "Zorić, Bojana and Janković, Ljiljana and Kuzmanović-Pfićer, Jovana and Zidverc-Trajković, Jasna and Mijajlović, Milija and Stanimirović, Dragan",
year = "2018",
abstract = "Background: Burning mouth syndrome (BMS) is an intraoral burning or dysaesthetic sensation, recurring daily for more than two hours during the period longer than 3 months. The objective was to evaluate and analyse the efficacy of serotonin reuptake inhibitor fluoxetine on psychological factors, as well as on pain in participants with BMS. Methods: In a 6-month study, 100 participants with primary and secondary BMS were divided into two groups-fluoxetine and control (placebo) and examined by the dentist and the neurologist. Depression and anxiety were estimated by Hamilton Scale for Depression (HAM-D) and Anxiety (HAM-A) and Beck Depression Inventory (BDI) and the pain intensity by visual analogue scale (VAS). Results: Mean age of the participants was 60.33 in fluoxetine group and 67.4 in control group. Most of the participants were female-74% in the fluoxetine and 78% in the control group. Statistical difference between the fluoxetine and the control group was found in HAM-D results (P  lt  .05). Values of other scales and VAS decreased significantly after the therapy in both groups (P  lt  .05). Conclusions: Our trial results indicate that fluoxetine therapy not only improves the psychological status of participants with BMS but also fluoxetine decreases the intensity of pain in these patients.",
publisher = "Wiley, Hoboken",
journal = "Gerodontology",
title = "The efficacy of fluoxetine in BMS-A cross-over study",
volume = "35",
number = "2",
pages = "123-128",
doi = "10.1111/ger.12332"
}
Zorić, B., Janković, L., Kuzmanović-Pfićer, J., Zidverc-Trajković, J., Mijajlović, M.,& Stanimirović, D.. (2018). The efficacy of fluoxetine in BMS-A cross-over study. in Gerodontology
Wiley, Hoboken., 35(2), 123-128.
https://doi.org/10.1111/ger.12332
Zorić B, Janković L, Kuzmanović-Pfićer J, Zidverc-Trajković J, Mijajlović M, Stanimirović D. The efficacy of fluoxetine in BMS-A cross-over study. in Gerodontology. 2018;35(2):123-128.
doi:10.1111/ger.12332 .
Zorić, Bojana, Janković, Ljiljana, Kuzmanović-Pfićer, Jovana, Zidverc-Trajković, Jasna, Mijajlović, Milija, Stanimirović, Dragan, "The efficacy of fluoxetine in BMS-A cross-over study" in Gerodontology, 35, no. 2 (2018):123-128,
https://doi.org/10.1111/ger.12332 . .
8
8
12

Hyposalivation and xerostomia in schizophrenic patients on psychotropic medications

Đorđević, V.; Đokić, Gorica; Domić, D.; Zivković, N.; Janković, Ljiljana; Miličić, Biljana; Đukić-Dejanović, Slavica

(Elsevier Science Bv, Amsterdam, 2016)

TY  - CONF
AU  - Đorđević, V.
AU  - Đokić, Gorica
AU  - Domić, D.
AU  - Zivković, N.
AU  - Janković, Ljiljana
AU  - Miličić, Biljana
AU  - Đukić-Dejanović, Slavica
PY  - 2016
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/2069
PB  - Elsevier Science Bv, Amsterdam
C3  - European Neuropsychopharmacology
T1  - Hyposalivation and xerostomia in schizophrenic patients on psychotropic medications
VL  - 26
SP  - S537
EP  - S537
DO  - 10.1016/S0924-977X(16)31576-0
ER  - 
@conference{
author = "Đorđević, V. and Đokić, Gorica and Domić, D. and Zivković, N. and Janković, Ljiljana and Miličić, Biljana and Đukić-Dejanović, Slavica",
year = "2016",
publisher = "Elsevier Science Bv, Amsterdam",
journal = "European Neuropsychopharmacology",
title = "Hyposalivation and xerostomia in schizophrenic patients on psychotropic medications",
volume = "26",
pages = "S537-S537",
doi = "10.1016/S0924-977X(16)31576-0"
}
Đorđević, V., Đokić, G., Domić, D., Zivković, N., Janković, L., Miličić, B.,& Đukić-Dejanović, S.. (2016). Hyposalivation and xerostomia in schizophrenic patients on psychotropic medications. in European Neuropsychopharmacology
Elsevier Science Bv, Amsterdam., 26, S537-S537.
https://doi.org/10.1016/S0924-977X(16)31576-0
Đorđević V, Đokić G, Domić D, Zivković N, Janković L, Miličić B, Đukić-Dejanović S. Hyposalivation and xerostomia in schizophrenic patients on psychotropic medications. in European Neuropsychopharmacology. 2016;26:S537-S537.
doi:10.1016/S0924-977X(16)31576-0 .
Đorđević, V., Đokić, Gorica, Domić, D., Zivković, N., Janković, Ljiljana, Miličić, Biljana, Đukić-Dejanović, Slavica, "Hyposalivation and xerostomia in schizophrenic patients on psychotropic medications" in European Neuropsychopharmacology, 26 (2016):S537-S537,
https://doi.org/10.1016/S0924-977X(16)31576-0 . .
1

Nigrostriatal dopaminergic system is involved in the pathogenesis of primary burning mouth syndrome: Transcranial sonography study

Mijajlović, M.; Zidverc-Trajković, Jasna; Stanimirović, Dragan; Janković, Ljiljana; Šternić, Nadežda

(Karger, Basel, 2014)

TY  - CONF
AU  - Mijajlović, M.
AU  - Zidverc-Trajković, Jasna
AU  - Stanimirović, Dragan
AU  - Janković, Ljiljana
AU  - Šternić, Nadežda
PY  - 2014
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1862
PB  - Karger, Basel
C3  - Cerebrovascular Diseases
T1  - Nigrostriatal dopaminergic system is involved in the pathogenesis of primary burning mouth syndrome: Transcranial sonography study
VL  - 37
SP  - 48
EP  - 49
UR  - https://hdl.handle.net/21.15107/rcub_smile_1862
ER  - 
@conference{
author = "Mijajlović, M. and Zidverc-Trajković, Jasna and Stanimirović, Dragan and Janković, Ljiljana and Šternić, Nadežda",
year = "2014",
publisher = "Karger, Basel",
journal = "Cerebrovascular Diseases",
title = "Nigrostriatal dopaminergic system is involved in the pathogenesis of primary burning mouth syndrome: Transcranial sonography study",
volume = "37",
pages = "48-49",
url = "https://hdl.handle.net/21.15107/rcub_smile_1862"
}
Mijajlović, M., Zidverc-Trajković, J., Stanimirović, D., Janković, L.,& Šternić, N.. (2014). Nigrostriatal dopaminergic system is involved in the pathogenesis of primary burning mouth syndrome: Transcranial sonography study. in Cerebrovascular Diseases
Karger, Basel., 37, 48-49.
https://hdl.handle.net/21.15107/rcub_smile_1862
Mijajlović M, Zidverc-Trajković J, Stanimirović D, Janković L, Šternić N. Nigrostriatal dopaminergic system is involved in the pathogenesis of primary burning mouth syndrome: Transcranial sonography study. in Cerebrovascular Diseases. 2014;37:48-49.
https://hdl.handle.net/21.15107/rcub_smile_1862 .
Mijajlović, M., Zidverc-Trajković, Jasna, Stanimirović, Dragan, Janković, Ljiljana, Šternić, Nadežda, "Nigrostriatal dopaminergic system is involved in the pathogenesis of primary burning mouth syndrome: Transcranial sonography study" in Cerebrovascular Diseases, 37 (2014):48-49,
https://hdl.handle.net/21.15107/rcub_smile_1862 .

TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk

Stanimirović, Dragan; Zeljić, Katarina; Janković, Ljiljana; Magić, Marko; Hadži-Mihailović, Miloš; Magić, Zvonko

(Wiley-Blackwell, Hoboken, 2013)

TY  - JOUR
AU  - Stanimirović, Dragan
AU  - Zeljić, Katarina
AU  - Janković, Ljiljana
AU  - Magić, Marko
AU  - Hadži-Mihailović, Miloš
AU  - Magić, Zvonko
PY  - 2013
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1818
AB  - The aim of this study was to assess whether polymorphisms in toll-like receptor (TLR) and cluster of differentiation 14 (CD14) genes are associated with oral lichen planus (OLP) risk and clinical course of the disease. The study group consisted of 101 patients with confirmed OLP and 104 healthy blood donors without systemic or oral mucosal diseases. Single nucleotide polymorphisms of TLR2 (rs3804099), TLR3 (rs3775291 and rs5743312), TLR4 (rs4986790 and rs4986791), and CD14 (rs2569190) genes were genotyped using real-time PCR or PCR-restriction fragment length polymorphism (PCR-RFLP). The rs5743312 TLR3 gene polymorphism was associated with increased OLP risk in comparison with the wild type genotype (OR = 15.984, P = 0.011). No association with OLP risk was observed for the polymorphisms studied in TLR2, TLR4 and CD14 genes or for the rs3775291 polymorphism of the TLR3 gene. The polymorphisms of the TLR3 gene were in linkage disequilibrium (D ' = 1, r(2) = 0.1). Identified haplotypes were not associated with the risk of OLP. The findings of the current study suggest that the TT genotype of the rs5743312 TLR3 gene polymorphism may play a significant role in the aetiology of OLP.
PB  - Wiley-Blackwell, Hoboken
T2  - European Journal of Oral Sciences
T1  - TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk
VL  - 121
IS  - 5
SP  - 421
EP  - 426
DO  - 10.1111/eos.12074
ER  - 
@article{
author = "Stanimirović, Dragan and Zeljić, Katarina and Janković, Ljiljana and Magić, Marko and Hadži-Mihailović, Miloš and Magić, Zvonko",
year = "2013",
abstract = "The aim of this study was to assess whether polymorphisms in toll-like receptor (TLR) and cluster of differentiation 14 (CD14) genes are associated with oral lichen planus (OLP) risk and clinical course of the disease. The study group consisted of 101 patients with confirmed OLP and 104 healthy blood donors without systemic or oral mucosal diseases. Single nucleotide polymorphisms of TLR2 (rs3804099), TLR3 (rs3775291 and rs5743312), TLR4 (rs4986790 and rs4986791), and CD14 (rs2569190) genes were genotyped using real-time PCR or PCR-restriction fragment length polymorphism (PCR-RFLP). The rs5743312 TLR3 gene polymorphism was associated with increased OLP risk in comparison with the wild type genotype (OR = 15.984, P = 0.011). No association with OLP risk was observed for the polymorphisms studied in TLR2, TLR4 and CD14 genes or for the rs3775291 polymorphism of the TLR3 gene. The polymorphisms of the TLR3 gene were in linkage disequilibrium (D ' = 1, r(2) = 0.1). Identified haplotypes were not associated with the risk of OLP. The findings of the current study suggest that the TT genotype of the rs5743312 TLR3 gene polymorphism may play a significant role in the aetiology of OLP.",
publisher = "Wiley-Blackwell, Hoboken",
journal = "European Journal of Oral Sciences",
title = "TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk",
volume = "121",
number = "5",
pages = "421-426",
doi = "10.1111/eos.12074"
}
Stanimirović, D., Zeljić, K., Janković, L., Magić, M., Hadži-Mihailović, M.,& Magić, Z.. (2013). TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk. in European Journal of Oral Sciences
Wiley-Blackwell, Hoboken., 121(5), 421-426.
https://doi.org/10.1111/eos.12074
Stanimirović D, Zeljić K, Janković L, Magić M, Hadži-Mihailović M, Magić Z. TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk. in European Journal of Oral Sciences. 2013;121(5):421-426.
doi:10.1111/eos.12074 .
Stanimirović, Dragan, Zeljić, Katarina, Janković, Ljiljana, Magić, Marko, Hadži-Mihailović, Miloš, Magić, Zvonko, "TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk" in European Journal of Oral Sciences, 121, no. 5 (2013):421-426,
https://doi.org/10.1111/eos.12074 . .
15
9
14

The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers

Besu, Irina; Janković, Ljiljana; Konić-Ristić, Aleksandra; Rasković, Sanvila; Besu, Valeri; Đurić, Milanko; Čakić, Saša; Magdu, Ileana Ursu; Juranić, Zorica

(Wiley-Blackwell, Hoboken, 2013)

TY  - JOUR
AU  - Besu, Irina
AU  - Janković, Ljiljana
AU  - Konić-Ristić, Aleksandra
AU  - Rasković, Sanvila
AU  - Besu, Valeri
AU  - Đurić, Milanko
AU  - Čakić, Saša
AU  - Magdu, Ileana Ursu
AU  - Juranić, Zorica
PY  - 2013
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1817
AB  - Background Recurrent aphthous ulcerations (RAU), or recurrent aphthous stomatitis, is recognized as one of the most common oral mucosal diseases worldwide. It was noted some connection between immunity to cow's milk proteins (CMP) and oral diseases. The goal of this study was to determine the prevalence of the increased levels of serum antibodies to specific cow's milk proteins (SCMP), constituents of cheese or of whey, by enzyme-linked immunosorbent assay (ELISA) test, in subjects who have RAU. Methods Fifty subjects with RAU and 50 healthy people, as controls (C), were included in this research. Levels of serum IgA, IgG, and IgE antibodies to SCMP were determined by ELISA. The statistical analysis of data was performed by Wilcoxon rank sum test with continuity correction. Results The levels of serum anti-SCMP IgA, IgG, and IgE antibodies were significantly higher in subjects with RAU in comparison with controls (P  lt  0.005). Conclusions These results indicate the strong association between high levels of serum anti-SCMP IgA, IgG, and IgE antibodies, especially to caseins: a-, beta-, and ?-casein from cow's milk and clinical manifestations of RAU. Serum immunity to the whey proteins in subjects with RAU was not in so high percentage expressed.
PB  - Wiley-Blackwell, Hoboken
T2  - Journal of Oral Pathology & Medicine
T1  - The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers
VL  - 42
IS  - 1
SP  - 82
EP  - 88
DO  - 10.1111/j.1600-0714.2012.01204.x
ER  - 
@article{
author = "Besu, Irina and Janković, Ljiljana and Konić-Ristić, Aleksandra and Rasković, Sanvila and Besu, Valeri and Đurić, Milanko and Čakić, Saša and Magdu, Ileana Ursu and Juranić, Zorica",
year = "2013",
abstract = "Background Recurrent aphthous ulcerations (RAU), or recurrent aphthous stomatitis, is recognized as one of the most common oral mucosal diseases worldwide. It was noted some connection between immunity to cow's milk proteins (CMP) and oral diseases. The goal of this study was to determine the prevalence of the increased levels of serum antibodies to specific cow's milk proteins (SCMP), constituents of cheese or of whey, by enzyme-linked immunosorbent assay (ELISA) test, in subjects who have RAU. Methods Fifty subjects with RAU and 50 healthy people, as controls (C), were included in this research. Levels of serum IgA, IgG, and IgE antibodies to SCMP were determined by ELISA. The statistical analysis of data was performed by Wilcoxon rank sum test with continuity correction. Results The levels of serum anti-SCMP IgA, IgG, and IgE antibodies were significantly higher in subjects with RAU in comparison with controls (P  lt  0.005). Conclusions These results indicate the strong association between high levels of serum anti-SCMP IgA, IgG, and IgE antibodies, especially to caseins: a-, beta-, and ?-casein from cow's milk and clinical manifestations of RAU. Serum immunity to the whey proteins in subjects with RAU was not in so high percentage expressed.",
publisher = "Wiley-Blackwell, Hoboken",
journal = "Journal of Oral Pathology & Medicine",
title = "The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers",
volume = "42",
number = "1",
pages = "82-88",
doi = "10.1111/j.1600-0714.2012.01204.x"
}
Besu, I., Janković, L., Konić-Ristić, A., Rasković, S., Besu, V., Đurić, M., Čakić, S., Magdu, I. U.,& Juranić, Z.. (2013). The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers. in Journal of Oral Pathology & Medicine
Wiley-Blackwell, Hoboken., 42(1), 82-88.
https://doi.org/10.1111/j.1600-0714.2012.01204.x
Besu I, Janković L, Konić-Ristić A, Rasković S, Besu V, Đurić M, Čakić S, Magdu IU, Juranić Z. The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers. in Journal of Oral Pathology & Medicine. 2013;42(1):82-88.
doi:10.1111/j.1600-0714.2012.01204.x .
Besu, Irina, Janković, Ljiljana, Konić-Ristić, Aleksandra, Rasković, Sanvila, Besu, Valeri, Đurić, Milanko, Čakić, Saša, Magdu, Ileana Ursu, Juranić, Zorica, "The role of specific cow's milk proteins in the etiology of recurrent aphthous ulcers" in Journal of Oral Pathology & Medicine, 42, no. 1 (2013):82-88,
https://doi.org/10.1111/j.1600-0714.2012.01204.x . .
3
9
5
7

Ki-67 expression in oral lichen planus

Hadži-Mihailović, Miloš; Čakić, Saša; Janković, Saša; Raybaud, Helene; Nedeljković, Nenad; Janković, Ljiljana

(Balkan Union of Oncology (B.U.ON.), 2012)

TY  - JOUR
AU  - Hadži-Mihailović, Miloš
AU  - Čakić, Saša
AU  - Janković, Saša
AU  - Raybaud, Helene
AU  - Nedeljković, Nenad
AU  - Janković, Ljiljana
PY  - 2012
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1748
AB  - Purpose: The monoclonal antibody Ki-67 detects a nuclear antigen that is present only in proliferating cells. This is of particular interest for the analysis of the proliferation rates of malignant tumors. The aim of this study was to investigate the malignant potential of oral lichen planus (OLP) on the basis of expression of Ki-67 in healthy individuals (HI), patients with OLP and patients with squamous cell carcinoma (SCC), and to see for any potential interdependence between Ki-67 expression and different clinical and histopathological parameters in OLP. Methods: Immunohistochemistry for Ki-67 was carried out using an avidin-biotin peroxidase complex method. Results: Ki-67 was more expressed in keratinocytes and lymphocytes of OLP patients compared with HI, but less compared with patients with SCC. Keratinocytes and lymphocytes stained with Ki-67 in OLP patients were significantly higher in males, and in OLP specimens showed less developed civatte bodies (CB) and thickening of the basal membrane (TBM). Conclusion: Ki-67 may not serve as prognostic biomarker in oral cancer development from the initially diagnosed OLP, but it could help selecting patients with higher need of follow up for prevention of malignancy.
PB  - Balkan Union of Oncology (B.U.ON.)
T2  - Journal of BUON
T1  - Ki-67 expression in oral lichen planus
VL  - 17
IS  - 1
SP  - 132
EP  - 137
UR  - https://hdl.handle.net/21.15107/rcub_smile_1748
ER  - 
@article{
author = "Hadži-Mihailović, Miloš and Čakić, Saša and Janković, Saša and Raybaud, Helene and Nedeljković, Nenad and Janković, Ljiljana",
year = "2012",
abstract = "Purpose: The monoclonal antibody Ki-67 detects a nuclear antigen that is present only in proliferating cells. This is of particular interest for the analysis of the proliferation rates of malignant tumors. The aim of this study was to investigate the malignant potential of oral lichen planus (OLP) on the basis of expression of Ki-67 in healthy individuals (HI), patients with OLP and patients with squamous cell carcinoma (SCC), and to see for any potential interdependence between Ki-67 expression and different clinical and histopathological parameters in OLP. Methods: Immunohistochemistry for Ki-67 was carried out using an avidin-biotin peroxidase complex method. Results: Ki-67 was more expressed in keratinocytes and lymphocytes of OLP patients compared with HI, but less compared with patients with SCC. Keratinocytes and lymphocytes stained with Ki-67 in OLP patients were significantly higher in males, and in OLP specimens showed less developed civatte bodies (CB) and thickening of the basal membrane (TBM). Conclusion: Ki-67 may not serve as prognostic biomarker in oral cancer development from the initially diagnosed OLP, but it could help selecting patients with higher need of follow up for prevention of malignancy.",
publisher = "Balkan Union of Oncology (B.U.ON.)",
journal = "Journal of BUON",
title = "Ki-67 expression in oral lichen planus",
volume = "17",
number = "1",
pages = "132-137",
url = "https://hdl.handle.net/21.15107/rcub_smile_1748"
}
Hadži-Mihailović, M., Čakić, S., Janković, S., Raybaud, H., Nedeljković, N.,& Janković, L.. (2012). Ki-67 expression in oral lichen planus. in Journal of BUON
Balkan Union of Oncology (B.U.ON.)., 17(1), 132-137.
https://hdl.handle.net/21.15107/rcub_smile_1748
Hadži-Mihailović M, Čakić S, Janković S, Raybaud H, Nedeljković N, Janković L. Ki-67 expression in oral lichen planus. in Journal of BUON. 2012;17(1):132-137.
https://hdl.handle.net/21.15107/rcub_smile_1748 .
Hadži-Mihailović, Miloš, Čakić, Saša, Janković, Saša, Raybaud, Helene, Nedeljković, Nenad, Janković, Ljiljana, "Ki-67 expression in oral lichen planus" in Journal of BUON, 17, no. 1 (2012):132-137,
https://hdl.handle.net/21.15107/rcub_smile_1748 .
4

Clinical and psychiatric manifestations of burning mouth syndrome

Mijajlović, Milija; Zidverc-Trajković, Jasna; Stanimirović, Dragan; Janković, Ljiljana; Šternić, Nadežda

(Klinički centar - Institut za neurologiju, Beograd i Institut za psihijatriju, Beograd, 2011)

TY  - JOUR
AU  - Mijajlović, Milija
AU  - Zidverc-Trajković, Jasna
AU  - Stanimirović, Dragan
AU  - Janković, Ljiljana
AU  - Šternić, Nadežda
PY  - 2011
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1653
AB  - According to International Headache Society (IHS) classification, burning mouth syndrome (BMS) is intra oral burning sensation without obvious medical and dental cause. IHS diagnostic criteria of the disorder include the presence of burning oral sensation during the most period of day without obvious changes of oral mucosa. Local and systemic causes have to be excluded by appropriate diagnostic procedures. Subjective feeling of dry mouth, paraesthesia and taste changes could be associated symptoms. Estimated prevalence of BMS in general population varies between 1 and 15% and the disorder is seven times more common in females. This condition is probably of multifactor origin, oft en idiopathic, and its etiology and pathogenesis has not been elucidated completely yet. More recently, increasing attention has been given to the altered perception of sensory functions as well as to the changes in the psychological profile of many BMS patients. As a result, both disturbances should be included in the clinical spectrum of BMS. BMS represents a disorder with a poor prognosis in terms of quality of life and treatment possibilities. As a result, BMS subjects continue to be high consumers of healthcare resources. As in the other chronic pain conditions it has been reported that depression and anxiety are strongly associated with BMS and that they are significantly more frequent in BMS patients than in non-BMS subjects.
AB  - Prema međunarodnoj klasifikaciji glavobolja Internacionalnog društva za glavobolje (International Headache Society-IHS), sindrom pečenja usta (burning mouth syndrome-BMS) predstavlja osećaj pečenja u usnoj duplji, a bez očiglednog medicinskog ili stomatološkog uzroka. IHS dijagnostički kriterijumi za ovaj poremećaj uključuju prisustvo senzacije pečenja u usnoj duplji za vreme najvećeg perioda dana, bez vidljivih promena sluznice usne duplje. Lokalni i sistemski uzroci moraju biti isključeni primenom odgovarajućih dijagnostičkih procedura. Subjektivni osećaj suvoće usta, parestezija i izmena osećaja ukusa mogu biti udruženi simptomi. Procenjena prevalenca BMS u opštoj populaciji varira između 1 i 15%, a poremećaj je sedam puta češći kod žena. Ovaj poremećaj je verovatno multifaktorijelnog porekla, često idiopatski, a njegova etiologija i patogeneza nisu u potpunosti razjašnjeni. U skorašnjim studijama, posebno se ističe značaj izmenjene percepcije senzornih funkcija i sistema kao i specifična promena psihološkog profi la mnogih pacijenata sa BMS. Zbog toga se preporučuje da oba navedena poremećaja budu uključena u klinički raznovrstan spektar BMS. BMS ima lošu prognozu u pogledu kvaliteta života obolelih i terapijskih mogućnosti, a kao rezultat ovaj poremećaj predstavlja veliki socio-ekonomski i medicinski problem. Kao i kod drugih hroničnih bolnih stanja, postoji značajna udruženost BMS sa depresijom i anksioznošću. Ovi ali i drugi psihijatrijski i psihološki poremećaji su značajno češći kod pacijenata sa BMS u odnosu na zdravu populaciju.
PB  - Klinički centar - Institut za neurologiju, Beograd i Institut za psihijatriju, Beograd
T2  - Aktuelnosti iz neurologije, psihijatrije i graničnih područja
T1  - Clinical and psychiatric manifestations of burning mouth syndrome
T1  - Kliničke i psihijatrijske manifestacije sindroma pečenja usta
VL  - 19
IS  - 3-4
SP  - 37
EP  - 43
UR  - https://hdl.handle.net/21.15107/rcub_smile_1653
ER  - 
@article{
author = "Mijajlović, Milija and Zidverc-Trajković, Jasna and Stanimirović, Dragan and Janković, Ljiljana and Šternić, Nadežda",
year = "2011",
abstract = "According to International Headache Society (IHS) classification, burning mouth syndrome (BMS) is intra oral burning sensation without obvious medical and dental cause. IHS diagnostic criteria of the disorder include the presence of burning oral sensation during the most period of day without obvious changes of oral mucosa. Local and systemic causes have to be excluded by appropriate diagnostic procedures. Subjective feeling of dry mouth, paraesthesia and taste changes could be associated symptoms. Estimated prevalence of BMS in general population varies between 1 and 15% and the disorder is seven times more common in females. This condition is probably of multifactor origin, oft en idiopathic, and its etiology and pathogenesis has not been elucidated completely yet. More recently, increasing attention has been given to the altered perception of sensory functions as well as to the changes in the psychological profile of many BMS patients. As a result, both disturbances should be included in the clinical spectrum of BMS. BMS represents a disorder with a poor prognosis in terms of quality of life and treatment possibilities. As a result, BMS subjects continue to be high consumers of healthcare resources. As in the other chronic pain conditions it has been reported that depression and anxiety are strongly associated with BMS and that they are significantly more frequent in BMS patients than in non-BMS subjects., Prema međunarodnoj klasifikaciji glavobolja Internacionalnog društva za glavobolje (International Headache Society-IHS), sindrom pečenja usta (burning mouth syndrome-BMS) predstavlja osećaj pečenja u usnoj duplji, a bez očiglednog medicinskog ili stomatološkog uzroka. IHS dijagnostički kriterijumi za ovaj poremećaj uključuju prisustvo senzacije pečenja u usnoj duplji za vreme najvećeg perioda dana, bez vidljivih promena sluznice usne duplje. Lokalni i sistemski uzroci moraju biti isključeni primenom odgovarajućih dijagnostičkih procedura. Subjektivni osećaj suvoće usta, parestezija i izmena osećaja ukusa mogu biti udruženi simptomi. Procenjena prevalenca BMS u opštoj populaciji varira između 1 i 15%, a poremećaj je sedam puta češći kod žena. Ovaj poremećaj je verovatno multifaktorijelnog porekla, često idiopatski, a njegova etiologija i patogeneza nisu u potpunosti razjašnjeni. U skorašnjim studijama, posebno se ističe značaj izmenjene percepcije senzornih funkcija i sistema kao i specifična promena psihološkog profi la mnogih pacijenata sa BMS. Zbog toga se preporučuje da oba navedena poremećaja budu uključena u klinički raznovrstan spektar BMS. BMS ima lošu prognozu u pogledu kvaliteta života obolelih i terapijskih mogućnosti, a kao rezultat ovaj poremećaj predstavlja veliki socio-ekonomski i medicinski problem. Kao i kod drugih hroničnih bolnih stanja, postoji značajna udruženost BMS sa depresijom i anksioznošću. Ovi ali i drugi psihijatrijski i psihološki poremećaji su značajno češći kod pacijenata sa BMS u odnosu na zdravu populaciju.",
publisher = "Klinički centar - Institut za neurologiju, Beograd i Institut za psihijatriju, Beograd",
journal = "Aktuelnosti iz neurologije, psihijatrije i graničnih područja",
title = "Clinical and psychiatric manifestations of burning mouth syndrome, Kliničke i psihijatrijske manifestacije sindroma pečenja usta",
volume = "19",
number = "3-4",
pages = "37-43",
url = "https://hdl.handle.net/21.15107/rcub_smile_1653"
}
Mijajlović, M., Zidverc-Trajković, J., Stanimirović, D., Janković, L.,& Šternić, N.. (2011). Clinical and psychiatric manifestations of burning mouth syndrome. in Aktuelnosti iz neurologije, psihijatrije i graničnih područja
Klinički centar - Institut za neurologiju, Beograd i Institut za psihijatriju, Beograd., 19(3-4), 37-43.
https://hdl.handle.net/21.15107/rcub_smile_1653
Mijajlović M, Zidverc-Trajković J, Stanimirović D, Janković L, Šternić N. Clinical and psychiatric manifestations of burning mouth syndrome. in Aktuelnosti iz neurologije, psihijatrije i graničnih područja. 2011;19(3-4):37-43.
https://hdl.handle.net/21.15107/rcub_smile_1653 .
Mijajlović, Milija, Zidverc-Trajković, Jasna, Stanimirović, Dragan, Janković, Ljiljana, Šternić, Nadežda, "Clinical and psychiatric manifestations of burning mouth syndrome" in Aktuelnosti iz neurologije, psihijatrije i graničnih područja, 19, no. 3-4 (2011):37-43,
https://hdl.handle.net/21.15107/rcub_smile_1653 .

Oral Health Status of Psychiatric In-patients in Serbia and Implications for Their Dental Care

Jovanović, Svetlana; Milovanović, Srđan; Gajić, Ivanka; Mandić, Jelena; Latas, Milan; Janković, Ljiljana

(Medicinska Naklada, Zagreb, 2010)

TY  - JOUR
AU  - Jovanović, Svetlana
AU  - Milovanović, Srđan
AU  - Gajić, Ivanka
AU  - Mandić, Jelena
AU  - Latas, Milan
AU  - Janković, Ljiljana
PY  - 2010
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1566
AB  - Aim To determine oral health status and identify predictors of oral health in a representative sample of psychiatric in-patients in Serbia Methods The study included 186 psychiatric in-patients and 186 control participants without psychiatric illness matched to the study group by age, sex, marital status, education level, employment, and monthly income Dental examinations were done in both groups to measure the following indices of oral health decayed, missing, and filled teeth (DMFT) index, community periodontal index, and plaque index. Participants were also interviewed about their dental health behavior and their medical records were examined Results Psychiatric in-patients had higher caries prevalence, poorer periodontal health, and poorer oral hygiene than controls The average DMFT score in the patient group was 24 4 and 16 1 in the control group (P  lt  0 001) Periodontal diseases were significantly more prevalent among psychiatric in-patients than among controls (P  lt  0 001) The average plaque index for patients was 2 78 and 1 40 for controls (P  lt  0 001) Multiple regression analysis demonstrated that 1) DMFT index was associated with age, male sex duration of mental illness, use of antidepressants, time since the last visit to the dentist, and snacking frequency, 2) community periodontal index was associated with male sex, and 3) plaque index was associated with age, male sex, education level, employment, monthly income, tooth brushing technique, and snacking frequency Conclusion Psychiatric in-patients in Serbia have poorer oral health than healthy controls It is necessary to intensify preventive dental care in this vulnerable population
PB  - Medicinska Naklada, Zagreb
T2  - Croatian Medical Journal
T1  - Oral Health Status of Psychiatric In-patients in Serbia and Implications for Their Dental Care
VL  - 51
IS  - 5
SP  - 443
EP  - 450
DO  - 10.3325/cmj.2010.51.443
ER  - 
@article{
author = "Jovanović, Svetlana and Milovanović, Srđan and Gajić, Ivanka and Mandić, Jelena and Latas, Milan and Janković, Ljiljana",
year = "2010",
abstract = "Aim To determine oral health status and identify predictors of oral health in a representative sample of psychiatric in-patients in Serbia Methods The study included 186 psychiatric in-patients and 186 control participants without psychiatric illness matched to the study group by age, sex, marital status, education level, employment, and monthly income Dental examinations were done in both groups to measure the following indices of oral health decayed, missing, and filled teeth (DMFT) index, community periodontal index, and plaque index. Participants were also interviewed about their dental health behavior and their medical records were examined Results Psychiatric in-patients had higher caries prevalence, poorer periodontal health, and poorer oral hygiene than controls The average DMFT score in the patient group was 24 4 and 16 1 in the control group (P  lt  0 001) Periodontal diseases were significantly more prevalent among psychiatric in-patients than among controls (P  lt  0 001) The average plaque index for patients was 2 78 and 1 40 for controls (P  lt  0 001) Multiple regression analysis demonstrated that 1) DMFT index was associated with age, male sex duration of mental illness, use of antidepressants, time since the last visit to the dentist, and snacking frequency, 2) community periodontal index was associated with male sex, and 3) plaque index was associated with age, male sex, education level, employment, monthly income, tooth brushing technique, and snacking frequency Conclusion Psychiatric in-patients in Serbia have poorer oral health than healthy controls It is necessary to intensify preventive dental care in this vulnerable population",
publisher = "Medicinska Naklada, Zagreb",
journal = "Croatian Medical Journal",
title = "Oral Health Status of Psychiatric In-patients in Serbia and Implications for Their Dental Care",
volume = "51",
number = "5",
pages = "443-450",
doi = "10.3325/cmj.2010.51.443"
}
Jovanović, S., Milovanović, S., Gajić, I., Mandić, J., Latas, M.,& Janković, L.. (2010). Oral Health Status of Psychiatric In-patients in Serbia and Implications for Their Dental Care. in Croatian Medical Journal
Medicinska Naklada, Zagreb., 51(5), 443-450.
https://doi.org/10.3325/cmj.2010.51.443
Jovanović S, Milovanović S, Gajić I, Mandić J, Latas M, Janković L. Oral Health Status of Psychiatric In-patients in Serbia and Implications for Their Dental Care. in Croatian Medical Journal. 2010;51(5):443-450.
doi:10.3325/cmj.2010.51.443 .
Jovanović, Svetlana, Milovanović, Srđan, Gajić, Ivanka, Mandić, Jelena, Latas, Milan, Janković, Ljiljana, "Oral Health Status of Psychiatric In-patients in Serbia and Implications for Their Dental Care" in Croatian Medical Journal, 51, no. 5 (2010):443-450,
https://doi.org/10.3325/cmj.2010.51.443 . .
35
23
33

Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus

Hadži-Mihailović, Miloš; Raybaud, Helene; Montei, R.; Čakić, Saša; Đurić, M.; Janković, Ljiljana

(Balkan Union of Oncology (B.U.ON.), 2010)

TY  - JOUR
AU  - Hadži-Mihailović, Miloš
AU  - Raybaud, Helene
AU  - Montei, R.
AU  - Čakić, Saša
AU  - Đurić, M.
AU  - Janković, Ljiljana
PY  - 2010
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1591
AB  - Purpose: The aim of this study was to investigate the malignant potential of oral lichen planus (OLP) on the basis of the expression of the Bcl-2 marker in healthy individuals (H), patients with OLP and patients with squamous cell carcinoma (SCC), and to establish potential interdependence between expression of Bcl-2 and the different clinical and histopathological parameters in H, OLP, and SCC. Methods: Immunohistochemistry for Bcl-2 was carried out using an avidin-biotin peroxidase complex method. Tissue sections were treated with mouse monoclonal antibody against Bcl-2 (124, DAKO A/S, Denmark; dilution 1/100). Immunohistochemical parameters measured included total tissue area, total stained area and intensity of stain. Results: Keratinocytes were not Bcl-2 positive in H and were sparsely positive in OLP. The number of lymphocytes stained with Bcl-2 was significantly lower in Has compared to patients with SCC and OLP. Bcl-2 staining was weak to moderate in OLP, and moderate to intense in SCC. Bcl-2-positive lymphocytes were more expressed in older OLP patients (>55 years), and in OLP specimens with orthokeratinized epithelium, less developed acanthosis and highest grade of lymphocyte expression. Conclusion: Bcl-2 may not serve as a prognostic biomarker in oral cancer development from OLP, but it could help in selecting patients with higher need of follow up to prevent malignancy.
PB  - Balkan Union of Oncology (B.U.ON.)
T2  - Journal of BUON
T1  - Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus
VL  - 15
IS  - 2
SP  - 362
EP  - 368
UR  - https://hdl.handle.net/21.15107/rcub_smile_1591
ER  - 
@article{
author = "Hadži-Mihailović, Miloš and Raybaud, Helene and Montei, R. and Čakić, Saša and Đurić, M. and Janković, Ljiljana",
year = "2010",
abstract = "Purpose: The aim of this study was to investigate the malignant potential of oral lichen planus (OLP) on the basis of the expression of the Bcl-2 marker in healthy individuals (H), patients with OLP and patients with squamous cell carcinoma (SCC), and to establish potential interdependence between expression of Bcl-2 and the different clinical and histopathological parameters in H, OLP, and SCC. Methods: Immunohistochemistry for Bcl-2 was carried out using an avidin-biotin peroxidase complex method. Tissue sections were treated with mouse monoclonal antibody against Bcl-2 (124, DAKO A/S, Denmark; dilution 1/100). Immunohistochemical parameters measured included total tissue area, total stained area and intensity of stain. Results: Keratinocytes were not Bcl-2 positive in H and were sparsely positive in OLP. The number of lymphocytes stained with Bcl-2 was significantly lower in Has compared to patients with SCC and OLP. Bcl-2 staining was weak to moderate in OLP, and moderate to intense in SCC. Bcl-2-positive lymphocytes were more expressed in older OLP patients (>55 years), and in OLP specimens with orthokeratinized epithelium, less developed acanthosis and highest grade of lymphocyte expression. Conclusion: Bcl-2 may not serve as a prognostic biomarker in oral cancer development from OLP, but it could help in selecting patients with higher need of follow up to prevent malignancy.",
publisher = "Balkan Union of Oncology (B.U.ON.)",
journal = "Journal of BUON",
title = "Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus",
volume = "15",
number = "2",
pages = "362-368",
url = "https://hdl.handle.net/21.15107/rcub_smile_1591"
}
Hadži-Mihailović, M., Raybaud, H., Montei, R., Čakić, S., Đurić, M.,& Janković, L.. (2010). Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus. in Journal of BUON
Balkan Union of Oncology (B.U.ON.)., 15(2), 362-368.
https://hdl.handle.net/21.15107/rcub_smile_1591
Hadži-Mihailović M, Raybaud H, Montei R, Čakić S, Đurić M, Janković L. Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus. in Journal of BUON. 2010;15(2):362-368.
https://hdl.handle.net/21.15107/rcub_smile_1591 .
Hadži-Mihailović, Miloš, Raybaud, Helene, Montei, R., Čakić, Saša, Đurić, M., Janković, Ljiljana, "Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus" in Journal of BUON, 15, no. 2 (2010):362-368,
https://hdl.handle.net/21.15107/rcub_smile_1591 .
8

Oral status in patients receiving 5-fluorouracil for colorectal cancer

Đurić, M.; Čakić, Saša; Hadži-Mihailović, Miloš; Petrović, D.; Janković, Ljiljana

(Balkan Union of Oncology (B.U.ON.), 2010)

TY  - JOUR
AU  - Đurić, M.
AU  - Čakić, Saša
AU  - Hadži-Mihailović, Miloš
AU  - Petrović, D.
AU  - Janković, Ljiljana
PY  - 2010
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1562
AB  - Purpose: Oral complications are frequent and troublesome symptoms for those undergoing chemotherapy for cancer Several antineoplastic agents are proved to have stomatotoxic potential, among them 5-fluorouracil (5-FU). The aim of the present study was to evaluate the oral status and patient experiences during chemotherapy with 5-FU for colorectal cancer Methods: Twenty-eight patients treated with 5-day 5-FU plus leucovorin entered this study. Positive data about oral symptoms were taken by anamnesis. Mucositis severity index, gingival index, plaque index, probing pocket depth and bleeding on probing have been used to assess oral mucosa and periodontal status of the patients. Patients were examined prior to chemotherapy and 14 days after the start of the chemotherapy cycle. Results: Mild to moderate subjective complaints concerning oral cavity were reported by 17.9% of patients before and 39.2% of patients after chemotherapy. Clinical examination revealed oral mucosa damage in 10.7% and 35.7% of patients, with mean mucositis score of 0.14 and 0.54 before and after chemotherapy, respectively. Although mean values of all periodontal indices were elevated after chemotherapy, only increase in gingival index was statistically significant (p=0.035). Mucositis was significantly correlated with oral pain (p=0.00), xerostomia (p=0.00), and plaque index (p=0.077), while the correlation between mucositis and the rest of the examined parameters was not significant. Conclusion: Oral complications were not highly expressed in this study Although 5-FU is considered to exert significant stomatotoxic effect, severe mucositis was far less common in this study compared to studies reported elsewhere.
PB  - Balkan Union of Oncology (B.U.ON.)
T2  - Journal of BUON
T1  - Oral status in patients receiving 5-fluorouracil for colorectal cancer
VL  - 15
IS  - 3
SP  - 475
EP  - 479
UR  - https://hdl.handle.net/21.15107/rcub_smile_1562
ER  - 
@article{
author = "Đurić, M. and Čakić, Saša and Hadži-Mihailović, Miloš and Petrović, D. and Janković, Ljiljana",
year = "2010",
abstract = "Purpose: Oral complications are frequent and troublesome symptoms for those undergoing chemotherapy for cancer Several antineoplastic agents are proved to have stomatotoxic potential, among them 5-fluorouracil (5-FU). The aim of the present study was to evaluate the oral status and patient experiences during chemotherapy with 5-FU for colorectal cancer Methods: Twenty-eight patients treated with 5-day 5-FU plus leucovorin entered this study. Positive data about oral symptoms were taken by anamnesis. Mucositis severity index, gingival index, plaque index, probing pocket depth and bleeding on probing have been used to assess oral mucosa and periodontal status of the patients. Patients were examined prior to chemotherapy and 14 days after the start of the chemotherapy cycle. Results: Mild to moderate subjective complaints concerning oral cavity were reported by 17.9% of patients before and 39.2% of patients after chemotherapy. Clinical examination revealed oral mucosa damage in 10.7% and 35.7% of patients, with mean mucositis score of 0.14 and 0.54 before and after chemotherapy, respectively. Although mean values of all periodontal indices were elevated after chemotherapy, only increase in gingival index was statistically significant (p=0.035). Mucositis was significantly correlated with oral pain (p=0.00), xerostomia (p=0.00), and plaque index (p=0.077), while the correlation between mucositis and the rest of the examined parameters was not significant. Conclusion: Oral complications were not highly expressed in this study Although 5-FU is considered to exert significant stomatotoxic effect, severe mucositis was far less common in this study compared to studies reported elsewhere.",
publisher = "Balkan Union of Oncology (B.U.ON.)",
journal = "Journal of BUON",
title = "Oral status in patients receiving 5-fluorouracil for colorectal cancer",
volume = "15",
number = "3",
pages = "475-479",
url = "https://hdl.handle.net/21.15107/rcub_smile_1562"
}
Đurić, M., Čakić, S., Hadži-Mihailović, M., Petrović, D.,& Janković, L.. (2010). Oral status in patients receiving 5-fluorouracil for colorectal cancer. in Journal of BUON
Balkan Union of Oncology (B.U.ON.)., 15(3), 475-479.
https://hdl.handle.net/21.15107/rcub_smile_1562
Đurić M, Čakić S, Hadži-Mihailović M, Petrović D, Janković L. Oral status in patients receiving 5-fluorouracil for colorectal cancer. in Journal of BUON. 2010;15(3):475-479.
https://hdl.handle.net/21.15107/rcub_smile_1562 .
Đurić, M., Čakić, Saša, Hadži-Mihailović, Miloš, Petrović, D., Janković, Ljiljana, "Oral status in patients receiving 5-fluorouracil for colorectal cancer" in Journal of BUON, 15, no. 3 (2010):475-479,
https://hdl.handle.net/21.15107/rcub_smile_1562 .
6

Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection

Đurić, Milanko; Janković, Ljiljana; Jovanović, Tanja; Pavlica, Dušan; Brkić, Snežana; Knežević, Aleksandra; Marković, Dubravka; Milašin, Jelena

(Wiley, Hoboken, 2009)

TY  - JOUR
AU  - Đurić, Milanko
AU  - Janković, Ljiljana
AU  - Jovanović, Tanja
AU  - Pavlica, Dušan
AU  - Brkić, Snežana
AU  - Knežević, Aleksandra
AU  - Marković, Dubravka
AU  - Milašin, Jelena
PY  - 2009
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1504
AB  - Oral reactivation of latent Herpes simplex virus (HSV) infection may easily occur in cancer patients. Virus reactivation can cause oral mucosa damage, worsen already existing lesions caused by stomatotoxic effect of cancer therapy and, whether symptomatic or asymptomatic, ample spreading and promote viral transmission. Polymerase chain reaction (PCR), cell-culture and direct immunofluorescence have been used to determine the frequency of oral HSV reactivation in 60 patients undergoing chemotherapy for different malignancies. By means of PCR, the presence of viral DNA was detected in 71.7% of patients prior to chemotherapy and in 85.0% after chemotherapy. 33.3% of patients before and 40.0% after chemotherapy were viral-culture positive, while 3.3% of patients before and 11.7% after chemotherapy were positive as shown by direct immunofluorescence. No significant difference in HSV-1 reactivation was found before and after chemotherapy. In addition, no significant difference was found when comparing HSV-1 reactivation in patients with and without mucositis. HSV-2 was not detected in any of the patients. Reactivation of latent HSV is exceptionally frequent in cancer patients. The results of this study suggest that virus reactivation occurs independently of cancer chemotherapy. The potential role of HSV reactivation in oral mucosa damage remains unclear.
PB  - Wiley, Hoboken
T2  - Journal of Oral Pathology & Medicine
T1  - Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection
VL  - 38
IS  - 2
SP  - 167
EP  - 173
DO  - 10.1111/j.1600-0714.2008.00684.x
ER  - 
@article{
author = "Đurić, Milanko and Janković, Ljiljana and Jovanović, Tanja and Pavlica, Dušan and Brkić, Snežana and Knežević, Aleksandra and Marković, Dubravka and Milašin, Jelena",
year = "2009",
abstract = "Oral reactivation of latent Herpes simplex virus (HSV) infection may easily occur in cancer patients. Virus reactivation can cause oral mucosa damage, worsen already existing lesions caused by stomatotoxic effect of cancer therapy and, whether symptomatic or asymptomatic, ample spreading and promote viral transmission. Polymerase chain reaction (PCR), cell-culture and direct immunofluorescence have been used to determine the frequency of oral HSV reactivation in 60 patients undergoing chemotherapy for different malignancies. By means of PCR, the presence of viral DNA was detected in 71.7% of patients prior to chemotherapy and in 85.0% after chemotherapy. 33.3% of patients before and 40.0% after chemotherapy were viral-culture positive, while 3.3% of patients before and 11.7% after chemotherapy were positive as shown by direct immunofluorescence. No significant difference in HSV-1 reactivation was found before and after chemotherapy. In addition, no significant difference was found when comparing HSV-1 reactivation in patients with and without mucositis. HSV-2 was not detected in any of the patients. Reactivation of latent HSV is exceptionally frequent in cancer patients. The results of this study suggest that virus reactivation occurs independently of cancer chemotherapy. The potential role of HSV reactivation in oral mucosa damage remains unclear.",
publisher = "Wiley, Hoboken",
journal = "Journal of Oral Pathology & Medicine",
title = "Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection",
volume = "38",
number = "2",
pages = "167-173",
doi = "10.1111/j.1600-0714.2008.00684.x"
}
Đurić, M., Janković, L., Jovanović, T., Pavlica, D., Brkić, S., Knežević, A., Marković, D.,& Milašin, J.. (2009). Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection. in Journal of Oral Pathology & Medicine
Wiley, Hoboken., 38(2), 167-173.
https://doi.org/10.1111/j.1600-0714.2008.00684.x
Đurić M, Janković L, Jovanović T, Pavlica D, Brkić S, Knežević A, Marković D, Milašin J. Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection. in Journal of Oral Pathology & Medicine. 2009;38(2):167-173.
doi:10.1111/j.1600-0714.2008.00684.x .
Đurić, Milanko, Janković, Ljiljana, Jovanović, Tanja, Pavlica, Dušan, Brkić, Snežana, Knežević, Aleksandra, Marković, Dubravka, Milašin, Jelena, "Prevalence of oral herpes simplex virus reactivation in cancer patients: a comparison of different techniques of viral detection" in Journal of Oral Pathology & Medicine, 38, no. 2 (2009):167-173,
https://doi.org/10.1111/j.1600-0714.2008.00684.x . .
33
28
33

Periodontal Therapy Improves Gastric Helicobacter pylori Eradication

Zarić, S.; Bojić, B.; Janković, Ljiljana; Dapčević, B.; Popović, Branka; Čakić, Saša; Milašin, Jelena

(Sage Publications Inc, Thousand Oaks, 2009)

TY  - JOUR
AU  - Zarić, S.
AU  - Bojić, B.
AU  - Janković, Ljiljana
AU  - Dapčević, B.
AU  - Popović, Branka
AU  - Čakić, Saša
AU  - Milašin, Jelena
PY  - 2009
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1501
AB  - The oral cavity has been proposed as a reservoir for H. pylori that could be responsible for the refractoriness of gastric infection to triple therapy (antibiotics, antimicrobials, and proton pump inhibitors). The aim of this study was to evaluate the efficiency of combined periodontal and triple therapy vs. triple therapy alone, in gastric H. pylori eradication in persons with H. pylori in the subgingival biofilm. Individuals positive for H. pylori in their gastric and oral samples, as determined by nested PCR, were treated either with periodontal and triple therapy or with triple therapy alone. Our results indicate that 77.3% of those treated with the combined therapy exhibited successful eradication of gastric H. pylori, compared with 47.6% who underwent only triple therapy. Analysis of these data suggests that periodontal treatment in combination with systemic therapy could be a promising approach to increasing the therapy's efficacy and decreasing the risk of infection recurrence.
PB  - Sage Publications Inc, Thousand Oaks
T2  - Journal of Dental Research
T1  - Periodontal Therapy Improves Gastric Helicobacter pylori Eradication
VL  - 88
IS  - 10
SP  - 946
EP  - 950
DO  - 10.1177/0022034509344559
ER  - 
@article{
author = "Zarić, S. and Bojić, B. and Janković, Ljiljana and Dapčević, B. and Popović, Branka and Čakić, Saša and Milašin, Jelena",
year = "2009",
abstract = "The oral cavity has been proposed as a reservoir for H. pylori that could be responsible for the refractoriness of gastric infection to triple therapy (antibiotics, antimicrobials, and proton pump inhibitors). The aim of this study was to evaluate the efficiency of combined periodontal and triple therapy vs. triple therapy alone, in gastric H. pylori eradication in persons with H. pylori in the subgingival biofilm. Individuals positive for H. pylori in their gastric and oral samples, as determined by nested PCR, were treated either with periodontal and triple therapy or with triple therapy alone. Our results indicate that 77.3% of those treated with the combined therapy exhibited successful eradication of gastric H. pylori, compared with 47.6% who underwent only triple therapy. Analysis of these data suggests that periodontal treatment in combination with systemic therapy could be a promising approach to increasing the therapy's efficacy and decreasing the risk of infection recurrence.",
publisher = "Sage Publications Inc, Thousand Oaks",
journal = "Journal of Dental Research",
title = "Periodontal Therapy Improves Gastric Helicobacter pylori Eradication",
volume = "88",
number = "10",
pages = "946-950",
doi = "10.1177/0022034509344559"
}
Zarić, S., Bojić, B., Janković, L., Dapčević, B., Popović, B., Čakić, S.,& Milašin, J.. (2009). Periodontal Therapy Improves Gastric Helicobacter pylori Eradication. in Journal of Dental Research
Sage Publications Inc, Thousand Oaks., 88(10), 946-950.
https://doi.org/10.1177/0022034509344559
Zarić S, Bojić B, Janković L, Dapčević B, Popović B, Čakić S, Milašin J. Periodontal Therapy Improves Gastric Helicobacter pylori Eradication. in Journal of Dental Research. 2009;88(10):946-950.
doi:10.1177/0022034509344559 .
Zarić, S., Bojić, B., Janković, Ljiljana, Dapčević, B., Popović, Branka, Čakić, Saša, Milašin, Jelena, "Periodontal Therapy Improves Gastric Helicobacter pylori Eradication" in Journal of Dental Research, 88, no. 10 (2009):946-950,
https://doi.org/10.1177/0022034509344559 . .
59
37
46

Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjögren's syndrome

Hadži-Mihailović, Miloš; Janković, Ljiljana; Čakić, Saša

(Srpsko lekarsko društvo, Beograd, 2009)

TY  - JOUR
AU  - Hadži-Mihailović, Miloš
AU  - Janković, Ljiljana
AU  - Čakić, Saša
PY  - 2009
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1466
AB  - Introduction. Sjögren's syndrome (SS) is a chronic autoimmune disorder, with its major clinical manifestations resulting from changes in exocrine glands. Objective The aim of this study was to evaluate serum concentrations of circulating immune complexes (CIC) and immunoglobulin G (IgG), and salivary proteins (SP) and salivary immunoglobulin A (sIgA) in 40 patients with SS, and to correlate these values among themselves, as well as with the unstimulated salivary flow rate (USFR) and the duration of disease. Methods. The total of 40 patients were included in this research. CIC was determined using the solution of polyethylene glycol and IgG with the standard procedure of radial immunodiffusion. SP was investigated by the method of Lowry and sIgA was separated from the whole saliva using the method of immune chromatography. Results. The values of most of the studied parameters exceeded the normal range in a high degree: CIC 72.5%, IgG 70%, SP 80%. The concentrations of CIC were significantly higher in the patients with the duration of disease less than 10 years. With the decrease of USFR, the concentration of sIgA and IgG were increased with statistical significance. Conclusion The increased prevalence of abnormal values of CIC, IgG and SP indicate that the patients with SS have developed a higher level of immune reactivity. These results could be useful in diagnosis and disease activity monitoring.
AB  - Uvod. Sjegrenov (Sjögren) sindrom (SS) je hronična autoimuna bolest koja nastaje usled patoloških promena u egzokrinim žlezdama. Cilj rada Cilj rada je bio da se koncentracije cirkulatornih imunih kompleksa (CIC) i imunoglobulina G (IgG) u serumu, kao i salivarnih proteina (SP) i salivarnog IgA (sIgA) u pljuvački uporede međusobno i u odnosu na stepen protoka nestimulisane pljuvačke (USFR) i trajanja bolesti. Metode rada. Istraživanje je obuhvatilo 40 bolesnika sa SS. CIC je bio određen korišćenjem rastvora polietilenglikola, a IgG standardnim postupkom radijalne imunodifuzije. SP su izolovani metodom po Loriju (Lowry), dok je sIgA izdvojen iz ukupne pljuvačke korišćenjem metode imune hromatografije. Rezultati. Koncentracije većine ispitanih parametara su u velikoj meri odstupale od njihovih normalnih vrednosti: CIC 72,5%, IgG 70%, SP 80%. Koncentracije CIC su bile statistički značajno veće kod bolesnika čija je bolest trajala manje od 10 godina. Sa smanjenjem USFR koncentracije sIgA i IgG su se povećavale sa statističkom značajnošću. Zaključak. Povećane koncentracije CIC, IgG i SP kod bolesnika sa SS upućuju na povišen nivo imunološke reaktivnosti. Podaci dobijeni u ovom istraživanju mogu biti korisni prilikom posmatranja aktivnosti i dinamike promena kod SS.
PB  - Srpsko lekarsko društvo, Beograd
T2  - Srpski arhiv za celokupno lekarstvo
T1  - Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjögren's syndrome
T1  - Cirkulatorni imuni kompleksi, imunoglobulin G, salivarni proteini i salivarni imunoglobulin A kod bolesnika sa Sjegrenovim sindromom
VL  - 137
IS  - 3-4
SP  - 134
EP  - 139
DO  - 10.2298/SARH0904134H
ER  - 
@article{
author = "Hadži-Mihailović, Miloš and Janković, Ljiljana and Čakić, Saša",
year = "2009",
abstract = "Introduction. Sjögren's syndrome (SS) is a chronic autoimmune disorder, with its major clinical manifestations resulting from changes in exocrine glands. Objective The aim of this study was to evaluate serum concentrations of circulating immune complexes (CIC) and immunoglobulin G (IgG), and salivary proteins (SP) and salivary immunoglobulin A (sIgA) in 40 patients with SS, and to correlate these values among themselves, as well as with the unstimulated salivary flow rate (USFR) and the duration of disease. Methods. The total of 40 patients were included in this research. CIC was determined using the solution of polyethylene glycol and IgG with the standard procedure of radial immunodiffusion. SP was investigated by the method of Lowry and sIgA was separated from the whole saliva using the method of immune chromatography. Results. The values of most of the studied parameters exceeded the normal range in a high degree: CIC 72.5%, IgG 70%, SP 80%. The concentrations of CIC were significantly higher in the patients with the duration of disease less than 10 years. With the decrease of USFR, the concentration of sIgA and IgG were increased with statistical significance. Conclusion The increased prevalence of abnormal values of CIC, IgG and SP indicate that the patients with SS have developed a higher level of immune reactivity. These results could be useful in diagnosis and disease activity monitoring., Uvod. Sjegrenov (Sjögren) sindrom (SS) je hronična autoimuna bolest koja nastaje usled patoloških promena u egzokrinim žlezdama. Cilj rada Cilj rada je bio da se koncentracije cirkulatornih imunih kompleksa (CIC) i imunoglobulina G (IgG) u serumu, kao i salivarnih proteina (SP) i salivarnog IgA (sIgA) u pljuvački uporede međusobno i u odnosu na stepen protoka nestimulisane pljuvačke (USFR) i trajanja bolesti. Metode rada. Istraživanje je obuhvatilo 40 bolesnika sa SS. CIC je bio određen korišćenjem rastvora polietilenglikola, a IgG standardnim postupkom radijalne imunodifuzije. SP su izolovani metodom po Loriju (Lowry), dok je sIgA izdvojen iz ukupne pljuvačke korišćenjem metode imune hromatografije. Rezultati. Koncentracije većine ispitanih parametara su u velikoj meri odstupale od njihovih normalnih vrednosti: CIC 72,5%, IgG 70%, SP 80%. Koncentracije CIC su bile statistički značajno veće kod bolesnika čija je bolest trajala manje od 10 godina. Sa smanjenjem USFR koncentracije sIgA i IgG su se povećavale sa statističkom značajnošću. Zaključak. Povećane koncentracije CIC, IgG i SP kod bolesnika sa SS upućuju na povišen nivo imunološke reaktivnosti. Podaci dobijeni u ovom istraživanju mogu biti korisni prilikom posmatranja aktivnosti i dinamike promena kod SS.",
publisher = "Srpsko lekarsko društvo, Beograd",
journal = "Srpski arhiv za celokupno lekarstvo",
title = "Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjögren's syndrome, Cirkulatorni imuni kompleksi, imunoglobulin G, salivarni proteini i salivarni imunoglobulin A kod bolesnika sa Sjegrenovim sindromom",
volume = "137",
number = "3-4",
pages = "134-139",
doi = "10.2298/SARH0904134H"
}
Hadži-Mihailović, M., Janković, L.,& Čakić, S.. (2009). Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjögren's syndrome. in Srpski arhiv za celokupno lekarstvo
Srpsko lekarsko društvo, Beograd., 137(3-4), 134-139.
https://doi.org/10.2298/SARH0904134H
Hadži-Mihailović M, Janković L, Čakić S. Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjögren's syndrome. in Srpski arhiv za celokupno lekarstvo. 2009;137(3-4):134-139.
doi:10.2298/SARH0904134H .
Hadži-Mihailović, Miloš, Janković, Ljiljana, Čakić, Saša, "Circulating immune complexes, immunoglobulin G, salivary proteins and salivary immunoglobulin A in patients with Sjögren's syndrome" in Srpski arhiv za celokupno lekarstvo, 137, no. 3-4 (2009):134-139,
https://doi.org/10.2298/SARH0904134H . .
3
3
3

Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome

Zidverc-Trajković, Jasna; Stanimirović, Dragan; Obrenović, Radmila; Tajti, Janos; Vecsei, Laszlo; Gardi, Janos; Nemeth, Jozsef; Mijajlović, Milija; Šternić, Nadežda; Janković, Ljiljana

(Wiley, Hoboken, 2009)

TY  - JOUR
AU  - Zidverc-Trajković, Jasna
AU  - Stanimirović, Dragan
AU  - Obrenović, Radmila
AU  - Tajti, Janos
AU  - Vecsei, Laszlo
AU  - Gardi, Janos
AU  - Nemeth, Jozsef
AU  - Mijajlović, Milija
AU  - Šternić, Nadežda
AU  - Janković, Ljiljana
PY  - 2009
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1513
AB  - Burning mouth syndrome (BMS) is an intraoral burning sensation for which no medical or dental cause can be found. Recent studies suggest that primary neuropathic dysfunction might be involved in the pathogenesis of BMS. Calcitonin gene-related peptide (CGRP) plays an important role in the development of pain and serves as a biological marker of trigeminovascular activation. The aim of this study was to determine the levels of CGRP in the saliva of BMS patients and estimate the trigeminovascular activation in BMS. CGRP levels were measured, by RIA method in 78 BMS patients and 16 healthy subjects. The levels of CGRP were non-significantly decreased in BMS patients in comparison to healthy subjects. These results suggest that trigeminal nerve degeneration may be the underlying cause of BMS.
PB  - Wiley, Hoboken
T2  - Journal of Oral Pathology & Medicine
T1  - Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome
VL  - 38
IS  - 1
SP  - 29
EP  - 33
DO  - 10.1111/j.1600-0714.2008.00721.x
ER  - 
@article{
author = "Zidverc-Trajković, Jasna and Stanimirović, Dragan and Obrenović, Radmila and Tajti, Janos and Vecsei, Laszlo and Gardi, Janos and Nemeth, Jozsef and Mijajlović, Milija and Šternić, Nadežda and Janković, Ljiljana",
year = "2009",
abstract = "Burning mouth syndrome (BMS) is an intraoral burning sensation for which no medical or dental cause can be found. Recent studies suggest that primary neuropathic dysfunction might be involved in the pathogenesis of BMS. Calcitonin gene-related peptide (CGRP) plays an important role in the development of pain and serves as a biological marker of trigeminovascular activation. The aim of this study was to determine the levels of CGRP in the saliva of BMS patients and estimate the trigeminovascular activation in BMS. CGRP levels were measured, by RIA method in 78 BMS patients and 16 healthy subjects. The levels of CGRP were non-significantly decreased in BMS patients in comparison to healthy subjects. These results suggest that trigeminal nerve degeneration may be the underlying cause of BMS.",
publisher = "Wiley, Hoboken",
journal = "Journal of Oral Pathology & Medicine",
title = "Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome",
volume = "38",
number = "1",
pages = "29-33",
doi = "10.1111/j.1600-0714.2008.00721.x"
}
Zidverc-Trajković, J., Stanimirović, D., Obrenović, R., Tajti, J., Vecsei, L., Gardi, J., Nemeth, J., Mijajlović, M., Šternić, N.,& Janković, L.. (2009). Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome. in Journal of Oral Pathology & Medicine
Wiley, Hoboken., 38(1), 29-33.
https://doi.org/10.1111/j.1600-0714.2008.00721.x
Zidverc-Trajković J, Stanimirović D, Obrenović R, Tajti J, Vecsei L, Gardi J, Nemeth J, Mijajlović M, Šternić N, Janković L. Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome. in Journal of Oral Pathology & Medicine. 2009;38(1):29-33.
doi:10.1111/j.1600-0714.2008.00721.x .
Zidverc-Trajković, Jasna, Stanimirović, Dragan, Obrenović, Radmila, Tajti, Janos, Vecsei, Laszlo, Gardi, Janos, Nemeth, Jozsef, Mijajlović, Milija, Šternić, Nadežda, Janković, Ljiljana, "Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome" in Journal of Oral Pathology & Medicine, 38, no. 1 (2009):29-33,
https://doi.org/10.1111/j.1600-0714.2008.00721.x . .
37
21
31

Expression of Fas/FasL in patients with oral lichen planus

Hadži-Mihailović, Miloš; Raybaud, Helene; Monteil, R.; Janković, Ljiljana

(Balkan Union of Oncology (B.U.ON.), 2009)

TY  - JOUR
AU  - Hadži-Mihailović, Miloš
AU  - Raybaud, Helene
AU  - Monteil, R.
AU  - Janković, Ljiljana
PY  - 2009
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1491
AB  - Purpose: To investigate the malignant potential of oral lichen planus (OLP) on the basis of expression of the Fas/FasL markers in healthy individuals (H), OLP patients and patients with squamous cell carcinoma (SCC). Patients and methods: 40 patients with OLP and two control groups were included in this research (H and patients with SCC). Immunohislochemistry for Fas and FasL was carried out using an avidin-biotin peroxidase complex method. Results: Only a low percentage of infiltrating lymphocytes and no keratinocytes were Fas-positive in OLP specimens. The highest percentage of Fas-staining keratinocytes in our survey was identified mostly in H and patients with well-differentiated SCC In most cases of SCC, OLP and H a high percentage of keratinocytes and lymphocytes were FasL-positive. FasL expression was negatively correlated with the degree of cell differentiation and apoptosis. Taking into consideration that all carcinomas in this survey were highly differentiated, it is not surprising that no statistically significant differences in FasL expression between H, OLP and SCC specimens were detected Conclusion: Downregulation of Fas expression in keratinocytes and lymphocytes of OLP specimens, together with upregulation of FasL, may serve as initial prognostic biomarker in oral cancer development.
PB  - Balkan Union of Oncology (B.U.ON.)
T2  - Journal of BUON
T1  - Expression of Fas/FasL in patients with oral lichen planus
VL  - 14
IS  - 3
SP  - 487
EP  - 493
UR  - https://hdl.handle.net/21.15107/rcub_smile_1491
ER  - 
@article{
author = "Hadži-Mihailović, Miloš and Raybaud, Helene and Monteil, R. and Janković, Ljiljana",
year = "2009",
abstract = "Purpose: To investigate the malignant potential of oral lichen planus (OLP) on the basis of expression of the Fas/FasL markers in healthy individuals (H), OLP patients and patients with squamous cell carcinoma (SCC). Patients and methods: 40 patients with OLP and two control groups were included in this research (H and patients with SCC). Immunohislochemistry for Fas and FasL was carried out using an avidin-biotin peroxidase complex method. Results: Only a low percentage of infiltrating lymphocytes and no keratinocytes were Fas-positive in OLP specimens. The highest percentage of Fas-staining keratinocytes in our survey was identified mostly in H and patients with well-differentiated SCC In most cases of SCC, OLP and H a high percentage of keratinocytes and lymphocytes were FasL-positive. FasL expression was negatively correlated with the degree of cell differentiation and apoptosis. Taking into consideration that all carcinomas in this survey were highly differentiated, it is not surprising that no statistically significant differences in FasL expression between H, OLP and SCC specimens were detected Conclusion: Downregulation of Fas expression in keratinocytes and lymphocytes of OLP specimens, together with upregulation of FasL, may serve as initial prognostic biomarker in oral cancer development.",
publisher = "Balkan Union of Oncology (B.U.ON.)",
journal = "Journal of BUON",
title = "Expression of Fas/FasL in patients with oral lichen planus",
volume = "14",
number = "3",
pages = "487-493",
url = "https://hdl.handle.net/21.15107/rcub_smile_1491"
}
Hadži-Mihailović, M., Raybaud, H., Monteil, R.,& Janković, L.. (2009). Expression of Fas/FasL in patients with oral lichen planus. in Journal of BUON
Balkan Union of Oncology (B.U.ON.)., 14(3), 487-493.
https://hdl.handle.net/21.15107/rcub_smile_1491
Hadži-Mihailović M, Raybaud H, Monteil R, Janković L. Expression of Fas/FasL in patients with oral lichen planus. in Journal of BUON. 2009;14(3):487-493.
https://hdl.handle.net/21.15107/rcub_smile_1491 .
Hadži-Mihailović, Miloš, Raybaud, Helene, Monteil, R., Janković, Ljiljana, "Expression of Fas/FasL in patients with oral lichen planus" in Journal of BUON, 14, no. 3 (2009):487-493,
https://hdl.handle.net/21.15107/rcub_smile_1491 .
8

The burning mouth syndrome: Clinical presentation and affective disorders

Mijajlović, M.; Zidverc-Trajković, Jasna; Janković, Ljiljana; Stanimirović, D.; Šternić, Nadežda

(Blackwell Publishing, Oxford, 2006)

TY  - CONF
AU  - Mijajlović, M.
AU  - Zidverc-Trajković, Jasna
AU  - Janković, Ljiljana
AU  - Stanimirović, D.
AU  - Šternić, Nadežda
PY  - 2006
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1284
PB  - Blackwell Publishing, Oxford
C3  - European Journal of Neurology
T1  - The burning mouth syndrome: Clinical presentation and affective disorders
VL  - 13
SP  - 249
EP  - 250
UR  - https://hdl.handle.net/21.15107/rcub_smile_1284
ER  - 
@conference{
author = "Mijajlović, M. and Zidverc-Trajković, Jasna and Janković, Ljiljana and Stanimirović, D. and Šternić, Nadežda",
year = "2006",
publisher = "Blackwell Publishing, Oxford",
journal = "European Journal of Neurology",
title = "The burning mouth syndrome: Clinical presentation and affective disorders",
volume = "13",
pages = "249-250",
url = "https://hdl.handle.net/21.15107/rcub_smile_1284"
}
Mijajlović, M., Zidverc-Trajković, J., Janković, L., Stanimirović, D.,& Šternić, N.. (2006). The burning mouth syndrome: Clinical presentation and affective disorders. in European Journal of Neurology
Blackwell Publishing, Oxford., 13, 249-250.
https://hdl.handle.net/21.15107/rcub_smile_1284
Mijajlović M, Zidverc-Trajković J, Janković L, Stanimirović D, Šternić N. The burning mouth syndrome: Clinical presentation and affective disorders. in European Journal of Neurology. 2006;13:249-250.
https://hdl.handle.net/21.15107/rcub_smile_1284 .
Mijajlović, M., Zidverc-Trajković, Jasna, Janković, Ljiljana, Stanimirović, D., Šternić, Nadežda, "The burning mouth syndrome: Clinical presentation and affective disorders" in European Journal of Neurology, 13 (2006):249-250,
https://hdl.handle.net/21.15107/rcub_smile_1284 .

The clinical presentation and affective disorders in burning mouth syndrome

Mijajlović, M.; Zidverc-Trajković, Jasna; Janković, Ljiljana; Stanimirović, D; Šternić, Nadežda

(Blackwell Publishing, Oxford, 2005)

TY  - CONF
AU  - Mijajlović, M.
AU  - Zidverc-Trajković, Jasna
AU  - Janković, Ljiljana
AU  - Stanimirović, D
AU  - Šternić, Nadežda
PY  - 2005
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1248
PB  - Blackwell Publishing, Oxford
C3  - Cephalalgia
T1  - The clinical presentation and affective disorders in burning mouth syndrome
VL  - 25
IS  - 10
SP  - 1017
EP  - 1017
UR  - https://hdl.handle.net/21.15107/rcub_smile_1248
ER  - 
@conference{
author = "Mijajlović, M. and Zidverc-Trajković, Jasna and Janković, Ljiljana and Stanimirović, D and Šternić, Nadežda",
year = "2005",
publisher = "Blackwell Publishing, Oxford",
journal = "Cephalalgia",
title = "The clinical presentation and affective disorders in burning mouth syndrome",
volume = "25",
number = "10",
pages = "1017-1017",
url = "https://hdl.handle.net/21.15107/rcub_smile_1248"
}
Mijajlović, M., Zidverc-Trajković, J., Janković, L., Stanimirović, D.,& Šternić, N.. (2005). The clinical presentation and affective disorders in burning mouth syndrome. in Cephalalgia
Blackwell Publishing, Oxford., 25(10), 1017-1017.
https://hdl.handle.net/21.15107/rcub_smile_1248
Mijajlović M, Zidverc-Trajković J, Janković L, Stanimirović D, Šternić N. The clinical presentation and affective disorders in burning mouth syndrome. in Cephalalgia. 2005;25(10):1017-1017.
https://hdl.handle.net/21.15107/rcub_smile_1248 .
Mijajlović, M., Zidverc-Trajković, Jasna, Janković, Ljiljana, Stanimirović, D, Šternić, Nadežda, "The clinical presentation and affective disorders in burning mouth syndrome" in Cephalalgia, 25, no. 10 (2005):1017-1017,
https://hdl.handle.net/21.15107/rcub_smile_1248 .

The clinical presentation and affective disorders in burning mouth syndrome

Mijajlović, M.; Zidverc-Trajković, Jasna; Janković, Ljiljana; Stanimirović, D; Šternić, Nadežda

(Elsevier Science Bv, Amsterdam, 2005)

TY  - CONF
AU  - Mijajlović, M.
AU  - Zidverc-Trajković, Jasna
AU  - Janković, Ljiljana
AU  - Stanimirović, D
AU  - Šternić, Nadežda
PY  - 2005
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1244
PB  - Elsevier Science Bv, Amsterdam
C3  - Journal of the Neurological Sciences
T1  - The clinical presentation and affective disorders in burning mouth syndrome
VL  - 238
SP  - S487
EP  - S487
UR  - https://hdl.handle.net/21.15107/rcub_smile_1244
ER  - 
@conference{
author = "Mijajlović, M. and Zidverc-Trajković, Jasna and Janković, Ljiljana and Stanimirović, D and Šternić, Nadežda",
year = "2005",
publisher = "Elsevier Science Bv, Amsterdam",
journal = "Journal of the Neurological Sciences",
title = "The clinical presentation and affective disorders in burning mouth syndrome",
volume = "238",
pages = "S487-S487",
url = "https://hdl.handle.net/21.15107/rcub_smile_1244"
}
Mijajlović, M., Zidverc-Trajković, J., Janković, L., Stanimirović, D.,& Šternić, N.. (2005). The clinical presentation and affective disorders in burning mouth syndrome. in Journal of the Neurological Sciences
Elsevier Science Bv, Amsterdam., 238, S487-S487.
https://hdl.handle.net/21.15107/rcub_smile_1244
Mijajlović M, Zidverc-Trajković J, Janković L, Stanimirović D, Šternić N. The clinical presentation and affective disorders in burning mouth syndrome. in Journal of the Neurological Sciences. 2005;238:S487-S487.
https://hdl.handle.net/21.15107/rcub_smile_1244 .
Mijajlović, M., Zidverc-Trajković, Jasna, Janković, Ljiljana, Stanimirović, D, Šternić, Nadežda, "The clinical presentation and affective disorders in burning mouth syndrome" in Journal of the Neurological Sciences, 238 (2005):S487-S487,
https://hdl.handle.net/21.15107/rcub_smile_1244 .

Association of unstimulated salivary flow rate and labial salivary gland histopathology with serologic features of Sjögren’s syndrome

Hadži-Mihailović, Miloš; Pucar, Ana; Janković, Ljiljana

(Udruženje stomatologa Balkana, 2003)

TY  - JOUR
AU  - Hadži-Mihailović, Miloš
AU  - Pucar, Ana
AU  - Janković, Ljiljana
PY  - 2003
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1173
AB  - Sjögren’s syndrome (SS) is a chronic autoimmune disorder with its major clinical manifestation resulting from changes in exocrine glands. An autoimmune etiology of SS is supported by the presence of autoantibodies specific for nuclear anti Ro (SS-A) and anti La (SS-B) antigens and other antinuclear antibodies (ANA) in sera of SS patients. The aim of the study was to evaluate the frequency of positive values of anti SS-A, anti SS-B antibodies and ANA in serum of 40 SS patients, and to correlate the above mentioned parameters with unstimulated salivary flow rate (USFR) and labial salivary gland focus score (LFS). Total of 40 patients was included in this research, 23 patients with primary SS and 17 with secondary SS. ANA was detected by the method of indirect immunofluorescence, and anti Ro/SS-A and anti La/SS-B antibodies were quantified by sandwich (Elisa) assay. The positive values of ANA were identified in plasma of 32 examined SS patients (80%), anti SS-A (Ro-52 kDa, Ro-60 kDa) antibodies were positive by 22 patients (55%), and anti SS-B antibodies were positive in less then 50% of examined SS patients (40%). The most presented were the patients with medium expressed xerostomia. Significant correlation between the unstimulated salivary flow rate and the positive values of ANA, anti Ro/SS-A, and anti La/SS-B antibodies could not be noticed. With increasing severity of disease there was an increase of the number of lymphocyte foci and a progressive loss of acinar tissue. High level of anti Ro/SS-A antibodies was found more often in plasma of the SS patients in a case of progressive loss of acinar tissue of the salivary gland (terminal stage), with statistical significance. It was concluded that the increased prevalence of positive values of anti Ro/SS-A antibodies and ANA indicates that the patient with SS has developed higher level of autoimmune reactivity. Level of anti Ro/SS-A antibodies in the peripheral blood of the patient with SS could be a significant marker of the degree of salivary/tissue destruction and disease severity.
PB  - Udruženje stomatologa Balkana
T2  - Balkan Journal of Stomatology
T1  - Association of unstimulated salivary flow rate and labial salivary gland histopathology with serologic features of Sjögren’s syndrome
VL  - 7
IS  - 2
SP  - 82
EP  - 86
UR  - https://hdl.handle.net/21.15107/rcub_smile_1173
ER  - 
@article{
author = "Hadži-Mihailović, Miloš and Pucar, Ana and Janković, Ljiljana",
year = "2003",
abstract = "Sjögren’s syndrome (SS) is a chronic autoimmune disorder with its major clinical manifestation resulting from changes in exocrine glands. An autoimmune etiology of SS is supported by the presence of autoantibodies specific for nuclear anti Ro (SS-A) and anti La (SS-B) antigens and other antinuclear antibodies (ANA) in sera of SS patients. The aim of the study was to evaluate the frequency of positive values of anti SS-A, anti SS-B antibodies and ANA in serum of 40 SS patients, and to correlate the above mentioned parameters with unstimulated salivary flow rate (USFR) and labial salivary gland focus score (LFS). Total of 40 patients was included in this research, 23 patients with primary SS and 17 with secondary SS. ANA was detected by the method of indirect immunofluorescence, and anti Ro/SS-A and anti La/SS-B antibodies were quantified by sandwich (Elisa) assay. The positive values of ANA were identified in plasma of 32 examined SS patients (80%), anti SS-A (Ro-52 kDa, Ro-60 kDa) antibodies were positive by 22 patients (55%), and anti SS-B antibodies were positive in less then 50% of examined SS patients (40%). The most presented were the patients with medium expressed xerostomia. Significant correlation between the unstimulated salivary flow rate and the positive values of ANA, anti Ro/SS-A, and anti La/SS-B antibodies could not be noticed. With increasing severity of disease there was an increase of the number of lymphocyte foci and a progressive loss of acinar tissue. High level of anti Ro/SS-A antibodies was found more often in plasma of the SS patients in a case of progressive loss of acinar tissue of the salivary gland (terminal stage), with statistical significance. It was concluded that the increased prevalence of positive values of anti Ro/SS-A antibodies and ANA indicates that the patient with SS has developed higher level of autoimmune reactivity. Level of anti Ro/SS-A antibodies in the peripheral blood of the patient with SS could be a significant marker of the degree of salivary/tissue destruction and disease severity.",
publisher = "Udruženje stomatologa Balkana",
journal = "Balkan Journal of Stomatology",
title = "Association of unstimulated salivary flow rate and labial salivary gland histopathology with serologic features of Sjögren’s syndrome",
volume = "7",
number = "2",
pages = "82-86",
url = "https://hdl.handle.net/21.15107/rcub_smile_1173"
}
Hadži-Mihailović, M., Pucar, A.,& Janković, L.. (2003). Association of unstimulated salivary flow rate and labial salivary gland histopathology with serologic features of Sjögren’s syndrome. in Balkan Journal of Stomatology
Udruženje stomatologa Balkana., 7(2), 82-86.
https://hdl.handle.net/21.15107/rcub_smile_1173
Hadži-Mihailović M, Pucar A, Janković L. Association of unstimulated salivary flow rate and labial salivary gland histopathology with serologic features of Sjögren’s syndrome. in Balkan Journal of Stomatology. 2003;7(2):82-86.
https://hdl.handle.net/21.15107/rcub_smile_1173 .
Hadži-Mihailović, Miloš, Pucar, Ana, Janković, Ljiljana, "Association of unstimulated salivary flow rate and labial salivary gland histopathology with serologic features of Sjögren’s syndrome" in Balkan Journal of Stomatology, 7, no. 2 (2003):82-86,
https://hdl.handle.net/21.15107/rcub_smile_1173 .

The epithelium of the periodontal pocket--an electron microscopy analysis

Danilović, Vesna; Janković, Ljiljana; Lacković, V.

(Društvo lekara Vojvodine Srpskog lekarskog društva, Novi Sad, 1997)

TY  - JOUR
AU  - Danilović, Vesna
AU  - Janković, Ljiljana
AU  - Lacković, V.
PY  - 1997
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/1079
AB  - The aim of this study was to examine intra- and intercellular changes that characterize the periodontal pocket epithelian. Biopsy specimens of human gingiva were prepared for an electron microscope study by a routine histological procedure. Results of the histological preparations analyses revealed changes significant for pathogenesis of gingivitis and periodontal disease because they cause destruction of epithelial barrier. Such a damaged periodontal pocket epithelium enables further invasion of harmful noxae and spreading of destructive processes into deeper parts of the periodontium.
PB  - Društvo lekara Vojvodine Srpskog lekarskog društva, Novi Sad
T2  - Medicinski pregled
T1  - The epithelium of the periodontal pocket--an electron microscopy analysis
T1  - Epitel parodontalnog dzepa--analiza elektronskim mikroskopom
VL  - 50
IS  - 3-4
SP  - 77
EP  - 80
UR  - https://hdl.handle.net/21.15107/rcub_smile_1079
ER  - 
@article{
author = "Danilović, Vesna and Janković, Ljiljana and Lacković, V.",
year = "1997",
abstract = "The aim of this study was to examine intra- and intercellular changes that characterize the periodontal pocket epithelian. Biopsy specimens of human gingiva were prepared for an electron microscope study by a routine histological procedure. Results of the histological preparations analyses revealed changes significant for pathogenesis of gingivitis and periodontal disease because they cause destruction of epithelial barrier. Such a damaged periodontal pocket epithelium enables further invasion of harmful noxae and spreading of destructive processes into deeper parts of the periodontium.",
publisher = "Društvo lekara Vojvodine Srpskog lekarskog društva, Novi Sad",
journal = "Medicinski pregled",
title = "The epithelium of the periodontal pocket--an electron microscopy analysis, Epitel parodontalnog dzepa--analiza elektronskim mikroskopom",
volume = "50",
number = "3-4",
pages = "77-80",
url = "https://hdl.handle.net/21.15107/rcub_smile_1079"
}
Danilović, V., Janković, L.,& Lacković, V.. (1997). The epithelium of the periodontal pocket--an electron microscopy analysis. in Medicinski pregled
Društvo lekara Vojvodine Srpskog lekarskog društva, Novi Sad., 50(3-4), 77-80.
https://hdl.handle.net/21.15107/rcub_smile_1079
Danilović V, Janković L, Lacković V. The epithelium of the periodontal pocket--an electron microscopy analysis. in Medicinski pregled. 1997;50(3-4):77-80.
https://hdl.handle.net/21.15107/rcub_smile_1079 .
Danilović, Vesna, Janković, Ljiljana, Lacković, V., "The epithelium of the periodontal pocket--an electron microscopy analysis" in Medicinski pregled, 50, no. 3-4 (1997):77-80,
https://hdl.handle.net/21.15107/rcub_smile_1079 .

Imunološke reakcije gingive u parodontopatiji

Janković, Ljiljana

(Univerzitet u Beogradu, Stomatološki fakultet, 1983)

TY  - THES
AU  - Janković, Ljiljana
PY  - 1983
UR  - https://plus.sr.cobiss.net/opac7/bib/35699212
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/157
PB  - Univerzitet u Beogradu, Stomatološki fakultet
T1  - Imunološke reakcije gingive u parodontopatiji
UR  - https://hdl.handle.net/21.15107/rcub_smile_157
ER  - 
@phdthesis{
author = "Janković, Ljiljana",
year = "1983",
publisher = "Univerzitet u Beogradu, Stomatološki fakultet",
title = "Imunološke reakcije gingive u parodontopatiji",
url = "https://hdl.handle.net/21.15107/rcub_smile_157"
}
Janković, L.. (1983). Imunološke reakcije gingive u parodontopatiji. 
Univerzitet u Beogradu, Stomatološki fakultet..
https://hdl.handle.net/21.15107/rcub_smile_157
Janković L. Imunološke reakcije gingive u parodontopatiji. 1983;.
https://hdl.handle.net/21.15107/rcub_smile_157 .
Janković, Ljiljana, "Imunološke reakcije gingive u parodontopatiji" (1983),
https://hdl.handle.net/21.15107/rcub_smile_157 .

Histološke promene gingive kao posledica imunoloških reakcija

Janković, Ljiljana

(Univerzitet u Beogradu, Stomatološki fakultet, 1981)

TY  - THES
AU  - Janković, Ljiljana
PY  - 1981
UR  - https://plus.sr.cobiss.net/opac7/bib/1024046990
UR  - https://smile.stomf.bg.ac.rs/handle/123456789/134
PB  - Univerzitet u Beogradu, Stomatološki fakultet
T1  - Histološke promene gingive kao posledica imunoloških reakcija
UR  - https://hdl.handle.net/21.15107/rcub_smile_134
ER  - 
@mastersthesis{
author = "Janković, Ljiljana",
year = "1981",
publisher = "Univerzitet u Beogradu, Stomatološki fakultet",
title = "Histološke promene gingive kao posledica imunoloških reakcija",
url = "https://hdl.handle.net/21.15107/rcub_smile_134"
}
Janković, L.. (1981). Histološke promene gingive kao posledica imunoloških reakcija. 
Univerzitet u Beogradu, Stomatološki fakultet..
https://hdl.handle.net/21.15107/rcub_smile_134
Janković L. Histološke promene gingive kao posledica imunoloških reakcija. 1981;.
https://hdl.handle.net/21.15107/rcub_smile_134 .
Janković, Ljiljana, "Histološke promene gingive kao posledica imunoloških reakcija" (1981),
https://hdl.handle.net/21.15107/rcub_smile_134 .